June 25, 2009
Homewood, Ill.—Silliker, a provider of consulting, testing, auditing, research and training services, acquired 100 percent of Biofortis, a French pioneer in nutrition clinical studies. The Contract Research Organization (CRO) offers two types of specialized services to clients: managing clinical trials to obtain scientific proof of claims for food and pharmaceutical products, health ingredients or additives; and developing specific biological markers. Through its "central lab," which specializes in metabolism disorders, Biofortis possesses the capabilities to integrate the most recent biomarkers into nutrition clinical studies. This acquisition is a key milestone for Silliker in its objective to enhance unique research services to food and ingredients manufacturers worldwide. One major area of innovation and development for these companies is related to their ability to provide healthier food with proven health benefits.
“As a leader in its field and with the continued leadership of (founder) Murielle Cazaubiel, Biofortis will complete and reinforce Silliker capabilities on a worldwide basis to support ingredients and food manufacturers throughout the product development process,” said Philippe Sans, CEO of Silliker.
“Being part of Silliker, Biofortis will be able to better leverage its expertise and thus accelerate its domestic and international development,” said Cazaubiel.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023
Radicle Insights—Covid Eris and dietary supplements: separating fact from fictionSep 21, 2023